{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T19:51:56Z","timestamp":1771962716204,"version":"3.50.1"},"reference-count":21,"publisher":"China Science Publishing & Media Ltd.","issue":"11","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2019,10,1]]},"DOI":"10.1093\/abbs\/gmz114","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T19:25:03Z","timestamp":1568143503000},"page":"1142-1147","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":20,"title":["Downregulation of MANCR inhibits cancer cell proliferation in mantle cell lymphoma possibly by interacting with RUNX2"],"prefix":"10.3724","volume":"51","author":[{"given":"Shujuan","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shune","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"key":"null","first-page":"83","volume":"102","author":"Sabattini E","year":"2010","unstructured":"Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica, 2010, 102: 83-87.","journal-title":"Pathologica"},{"key":"null","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000000628","volume":"40","author":"Bermudez G","year":"2016","unstructured":"Bermudez G, Gonz\u00e1lez de Villambros\u00eda S, Mart\u00ednez-L\u00f3pez A, Batlle A, Revert-Arce JB, Cereceda Company L, Ortega Bezanilla C. Incidental and isolated follicular lymphoma in situ and mantle cell lymphoma in situ lack clinical significance. Am J Surg Pathol, 2016, 40: 943-949.","journal-title":"Am J Surg Pathol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1200\/JCO.2015.63.5904","volume":"34","author":"Cheah CY","year":"2016","unstructured":"Cheah CY, Seymour JF, Wang ML. Mantle cell lymphoma. J Clin Oncol, 2016, 34: 1256-1269.","journal-title":"J Clin Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/annonc\/mdv111","volume":"26","author":"Cheah CY","year":"2015","unstructured":"Cheah CY, Chihara D, Romaguera JE, Fowler NH, Seymour JF, Hagemeister FB, Champlin RE. Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes. Ann Oncol, 2015, 26: 1175-1179.","journal-title":"Ann Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjh.14241","volume":"175","author":"Eskelund CW","year":"2016","unstructured":"Eskelund CW, Kolstad A, Jerkeman M, R\u00e4ty R, Laurell A, Eloranta S, Smedby KE. 15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL 2): prolonged remissions without survival plateau. Br J Haematol, 2016, 175: 410-418.","journal-title":"Br J Haematol"},{"key":"null","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","volume":"111","author":"Hoster E","year":"2008","unstructured":"Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood, 2008, 111: 558-565.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1038\/onc.2011.621","volume":"31","author":"Spizzo R","year":"2012","unstructured":"Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene, 2012, 31: 4577-4587.","journal-title":"Oncogene"},{"key":"null","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4161\/rna.20481","volume":"9","author":"Gutschner T","year":"2012","unstructured":"Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol, 2012, 9: 703-719.","journal-title":"RNA Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1158\/1541-7786.MCR-17-0548","volume":"16","author":"Tracy KM","year":"2018","unstructured":"Tracy KM, Tye CE, Ghule PN, Malaby HLH, Stumpff J, Stein JL, Stein GS. Mitotically-associated lncRNA (MANCR) affects genomic stability and cell division in aggressive breast cancer. Mol Cancer Res, 2018, 16: 587-598.","journal-title":"Mol Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1186\/bcr2762","volume":"12","author":"Leong DT","year":"2010","unstructured":"Leong DT, Lim J, Goh X, Pratap J, Pereira BP, Kwok HS, Nathan SS. Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility. Breast Cancer Res, 2010, 12:","journal-title":"Breast Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/jcp.24218","volume":"228","author":"Lucero CMJ","year":"2013","unstructured":"Lucero CMJ, Vega OA, Osorio MM, Tapia JC, Antonelli M, Stein GS, van Wijnen AJ. The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines. J Cell Physiol, 2013, 228: 714-723.","journal-title":"J Cell Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1128\/MCB.25.19.8581-8591.2005","volume":"25","author":"Pratap J","year":"2005","unstructured":"Pratap J, Aaved J, Languino LR, van Wijnen AJ, Stein JL, Stein GS, Lian JB. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol, 2005, 25: 8581-8591.","journal-title":"Mol Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"80223","DOI":"10.18632\/oncotarget.17956","volume":"8","author":"Hu G","year":"2017","unstructured":"Hu G, Gupta SK, Troska TP, Nair A, Gupta M. Long non-coding RNA profile in mantle cell lymphoma identifies a functional lncRNA ROR1-AS1 associated with EZH2\/PRC2 complex. Oncotarget, 2017, 8: 80223-80234.","journal-title":"Oncotarget"},{"key":"null","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12967-016-1100-9","volume":"14","author":"Wang X","year":"2016","unstructured":"Wang X, Sehgal L, Jain N, Khashab T, Mathur R, Samaniego F. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2. J Transl Med, 2016, 14:","journal-title":"J Transl Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/onc.2015.91","volume":"35","author":"Ge C","year":"2016","unstructured":"Ge C, Zhao G, Li Y, Li H, Zhao X, Pannone G, Bufo P. Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease. Oncogene, 2016, 35: 366-376.","journal-title":"Oncogene"},{"key":"null","doi-asserted-by":"crossref","first-page":"20999","DOI":"10.18632\/oncotarget.8236","volume":"7","author":"Guo ZJ","year":"2016","unstructured":"Guo ZJ, Yang L, Qian F, Wang YX, Yu X, Ji CD, Cui W. Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer. Oncotarget, 2016, 7: 20999-21012.","journal-title":"Oncotarget"},{"key":"null","doi-asserted-by":"crossref","first-page":"e2572","DOI":"10.1038\/cddis.2017.15","volume":"8","author":"Colden M","year":"2017","unstructured":"Colden M, Dar AA, Saini S, Priya VD, Shahryari V, Yamamura S, Tanaka Y. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. Cell Death Dis, 2017, 8:","journal-title":"Cell Death Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/FJC.0000000000000244","volume":"66","author":"Wang Y","year":"2015","unstructured":"Wang Y, Chen S, Deng C, Li F, Wang Y, Hu X, Shi F. MicroRNA-204 targets Runx2 to attenuate BMP-2-induced osteoblast differentiation of human aortic valve interstitial cells. J Cardiovasc Pharmacol, 2015, 66: 63-71.","journal-title":"J Cardiovasc Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1016\/j.cellsig.2014.09.011","volume":"26","author":"Yu W","year":"2014","unstructured":"Yu W, Qiao Y, Tang X, Ma L, Wang Y, Zhang X, Weng W. Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells. Cell Signal, 2014, 26: 2961-2968.","journal-title":"Cell Signal"},{"key":"null","first-page":"48","volume":"23","author":"Yu X","year":"2018","unstructured":"Yu X, Zhao J, He Y. Long non-coding RNA PVT1 functions as an oncogene in human colon cancer through miR-30d-5p\/RUNX2 axis. J BUON, 2018, 23: 48-54.","journal-title":"J BUON"},{"key":"null","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s13277-015-3831-2","volume":"37","author":"Xie J","year":"2016","unstructured":"Xie J, Yu F, Li D, hu X, Zhang X, Lv Z. MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2. Tumuor Biol, 2016, 37: 1197-1204.","journal-title":"Tumuor Biol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/718E6EF5D5904BA0B101F187AEFD6AD1","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmz114","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/abbs\/advance-article-pdf\/doi\/10.1093\/abbs\/gmz114\/30296652\/gmz114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/718E6EF5D5904BA0B101F187AEFD6AD1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T02:56:00Z","timestamp":1664333760000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmz114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":21,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,10,24]]},"published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmz114","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,1]]}}}